Multiple studies out indicate that a patient’s response to immune checkpoint blockade may depend on B cells located in special structures within the tumor.
Click here for original story, B-cell enrichment predictive of immunotherapy response in melanoma, sarcoma and kidney cancer
Source: ScienceDaily